S2-E7.2 – The Newer Diabetes Drugs and NASH: How T2D Patients are likely to respond

Wayne Eskridge describes some of the opportunities and concerns that affect diabetic patients might experience as they learn about NASH and the liver issues related to diabetes.

Patient, patient advocate and Fatty Liver Foundation Wayne Eskridge considers ways that diabetic patients might respond to the joint ideas that they have fatty liver issues and that some diabetes drugs might treat them. He considers issues of information overload and education and the pivotal role physician advocacy plays in driving that education. The other panelists discuss the need for multiple specialties to collaborate in educating patients and providing a more holistic view of how the metabolic diseases interact to damage patient health.

How useful was this post?

Click on a star to rate it!

Average rating / 5. Vote count:

No votes so far! Be the first to rate this post.

Request A Transcript of This Episode
Request Transcript

Join The Discussion…

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Join The Discussion!

Subscribe to our free emails. Receive access to our Discussion Group. Ask your questions directly to our "Surfers"